Biotech RadarJobs updated

COMPANY

American CryoStem

HQ: Eatontown, NJ source · americancryostem.com ↗

Clinical Phase 1

Location: Eatontown, NJ · source · Aug 22, 2022

Profile checked Oct 10, 2026

Keywords: Post-Concussion Syndrome Long COVID Multiple Sclerosis ATCell Autologous adipose derived mesenchymal cells

3Trials (company is sponsor)

Timeline

  1. Trial start Phase 1: Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 Infection source ↗
  2. Trial start Phase 1: ATCell™ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed Via Intravenous Infusion source ↗
  3. Trial start Phase 1: Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis source ↗

Clinical trials (lead sponsor) 3

RecordTitlePhaseStatusStartPrimary completion
NCT04744051ATCell™ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed Via Intravenous InfusionPhase 1Unknown status (ClinicalTrials.gov)Feb 1, 2021Sep 30, 2023 (estimated)
NCT05669261Treatment of Long COVID Symptoms Utilizing Autologous Stem Cells Following COVID-19 InfectionPhase 1Unknown status (ClinicalTrials.gov)Aug 1, 2023Dec 31, 2023 (estimated)
NCT02326935Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple SclerosisPhase 1Terminated2014-11May 18, 2018 (actual)
Feedback